The latest price target for Dynavax Technologies (NASDAQ:DVAX) was reported by HC Wainwright & Co. on January 14, 2025. The analyst firm set a price target for $31.00 expecting DVAX to rise to within 12 months (a possible 144.87% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Dynavax Technologies (NASDAQ:DVAX) was provided by HC Wainwright & Co., and Dynavax Technologies maintained their buy rating.

There is no last upgrade for Dynavax Technologies

There is no last downgrade for Dynavax Technologies.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on January 14, 2025 so you should expect the next rating to be made available sometime around January 14, 2026.

While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a maintained with a price target of $29.00 to $31.00. The current price Dynavax Technologies (DVAX) is trading at is $12.66, which is out of the analyst’s predicted range.